Enhanced Silk Protein Fragment Compositions and Production Methods
Legal Citation
Summary of the Inventive Concept
This inventive concept introduces a suite of direct improvements and enhancements to the original stable silk protein fragment compositions, focusing on purity, scalability, tailored molecular weights, bioavailability, and mechanical properties.
Background and Problem Solved
The original patent on stable silk protein fragment compositions has inherent limitations, such as impurities, scalability issues, and limited control over molecular weights and polydispersity. These limitations hinder the widespread adoption of silk-based materials in various industries. The new inventive concept addresses these limitations by introducing novel methods and compositions that enhance the purity, scalability, and properties of silk protein fragments.
Detailed Description of the Inventive Concept
The inventive concept encompasses five key aspects: (1) a method for producing pure and highly scalable silk protein fragment mixture solutions using nanofiltration membranes; (2) a system for generating silk protein fragments with tailored molecular weights and polydispersity using a processor-controlled mechanical fragmentation device and real-time molecular weight analyzer; (3) a composition of silk fibroin protein fragments with enhanced bioavailability, achieved through encapsulation in a biocompatible polymer matrix; (4) a method for creating silk-based composites with improved mechanical properties, involving the combination of silk protein fragments with a cross-linking agent and controlled temperature and pressure profiles; and (5) a device for rapid and efficient production of silk protein fragments, featuring a high-shear mixing chamber and microfluidic channel for precise control of fragmentation conditions.
Novelty and Inventive Step
The new claims introduce novel and non-obvious improvements to the original patent, including the use of nanofiltration membranes, processor-controlled mechanical fragmentation devices, and biocompatible polymer matrices. These innovations enable the production of higher-purity, more scalable, and more tailored silk protein fragments, which were not achievable with the original patent.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different types of filtration membranes, mechanical fragmentation devices, or biocompatible polymer matrices. Additionally, the inventive concept could be adapted for the production of silk protein fragments with specific properties, such as enhanced solubility or thermal stability.
Potential Commercial Applications and Market
The enhanced silk protein fragment compositions and production methods have significant commercial potential in various industries, including biomedical materials, textiles, and cosmetics. The target market includes companies and research institutions seeking to develop novel silk-based materials with improved properties and scalability.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K8/64 |
| A | A45 | A45D33/00 |
| A | A61 | A61K8/02 |
| A | A61 | A61K8/0216 |
| A | A61 | A61K8/042 |
| A | A61 | A61K8/19 |
| A | A61 | A61K8/27 |
| A | A61 | A61K8/29 |
| A | A61 | A61K8/365 |
| A | A61 | A61K8/4953 |
| A | A61 | A61K8/676 |
| A | A61 | A61K8/735 |
| A | A61 | A61K8/922 |
| A | A61 | A61K8/97 |
| A | A61 | A61K8/9789 |
| A | A61 | A61K8/9794 |
| A | A61 | A61K8/987 |
| A | A61 | A61K9/08 |
| A | A61 | A61K31/375 |
| A | A61 | A61K38/00 |
| A | A61 | A61K38/012 |
| A | A61 | A61K45/06 |
| A | A61 | A61K47/02 |
| A | A61 | A61K47/12 |
| A | A61 | A61K47/36 |
| A | A61 | A61Q17/04 |
| A | A61 | A61Q19/00 |
| A | A61 | A61Q19/007 |
| A | A61 | A61Q19/02 |
| A | A61 | A61Q19/08 |
| C | C07 | C07K1/12 |
| C | C07 | C07K14/43586 |
| A | A61 | A61K2800/591 |
| A | A61 | A61K2800/72 |
| A | A61 | A61K2800/74 |
| A | A61 | A61K2800/75 |
Original Patent Information
| Patent Number | US 11,857,664 |
|---|---|
| Title | Stable silk protein fragment compositions |
| Assignee(s) | EVOLVED BY NATURE, INC. |